XML 35 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF CASH FLOW (USD $)
 12 Months Ended 120 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (3,912,326) $ (4,556,538) $ (32,328,365)
Adjustment to reconcile net loss to net cash used in operating activities      
Amortization of deferred charges       4,392,456
Amortization of prepaid expenses       75,000
Warrants issued for services 135,851 291,326 4,194,624
Stock options issued for services 674,897 1,816,430 7,464,705
Common stock issued for services and fees 212,156 132,420 1,668,447
Purchase right agreement amortization       132,058
Depreciation and amortization of patents 126,773 79,217 349,417
Realized gain on investments       (3,911)
Realized gain on disposal of assets       (637)
(Increase) decrease in assets      
Receivables       (30,461)
Prepaid expenses and other current assets (42,229) (48,219) (132,204)
Increase (decrease) in liabilities      
Accounts payable (30,974) (43,449) 198,325
Accounts payable and accrued expenses- related parties (6,789) (14,610) (42,109)
Accrued expenses 4,611 (25,039) 85,489
Net cash used in operating activities (2,838,030) (2,368,462) (13,977,166)
CASH FLOWS FROM INVESTING ACTIVITIES      
Cost of intangibles (69,875) (83,248) (592,910)
Proceeds from sale of available for sale securities       203,911
Proceeds from receipt of note receivable       100,000
Purchase of available for sale securities       (200,000)
Purchase of equipment, furniture and leasehold improvements (109,278) (265,634) (561,157)
Net cash used in investing activities (179,153) (348,882) (1,050,156)
CASH FLOWS FROM FINANCING ACTIVITIES      
Issuance of common stock, private placement       7,495,524
Common stock rescinded, private placement       (200,000)
Issuance of common stock, exercise of options and warrants 72,508 444,400 2,093,912
Issuance of common stock, exercise of purchase right agreement       45,138
Issuance of common stock, institutional investor 2,278,500 4,849,999 7,328,499
Repayment of notes payable       (14,970)
Proceeds from subscription receivable       19,000
Advances to stockholders       (4,933)
Proceeds from convertible notes       529,000
Advances from officers       1,498
Net cash provided by financing activities 2,351,008 5,294,399 17,292,668
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (666,175) 2,577,055 2,265,346
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 2,936,879 359,824 5,328
CASH AND CASH EQUIVALENTS - END OF PERIOD   2,936,879  
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION      
CASH PAID DURING THE PERIOD FOR: Interest    109 23,341
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES      
Common stock issued in exchange for deferred charges       3,142,400
Warrants issued in exchange for deferred charges       1,581,056
Common stock issued as settlement for accounts payable       74,708
Accrued interest contributed as capital       35,624
Common stock issued in the conversion of notes payable       529,000
Acquisition of automobile through loan payable       24,643
Common stock issued upon exercise of a warrant in exchange for receivable       75,000
Insurance company pay off of note payable       9,673
Receivable for issuance of common stock       210,001
Contribution of officer accrued payroll       52,129
Common stock issued for prepaid expense       $ 75,000